Endocrine amyloid - A subject of increasing interest for the next century

Amyloid

Volumn 7, Issue 1, 2000, Pages 19-22

  Westermark, Gunilla T ^a   Westermark, Per ^b,c  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Amyloid; Atrial natriuretic peptide; Calcitonin; Insulin; Islet amyloid polypeptide; Polypeptide hormone; Prolactin

Indexed keywords

AMYLIN; AMYLOID PROTEIN; ATRIAL NATRIURETIC FACTOR; CALCITONIN; INSULIN; PEPTIDE HORMONE; PROLACTIN;

AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; ENDOCRINE TUMOR; HUMAN; HUMAN TISSUE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; THYROID CARCINOMA;

EID: 0034070177     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120009146819     Document Type: Article

References (23)

1. Sletten K, Westermark P and Natvig JB (1976). Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 143, 993-998
2. Glenner GG, Eanes ED, Bladen HA, Linke RP and Termine JD (1974). β-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 22, 1141-1158
3. Westermark P (1974). On the nature of the amyloid in human islets of Langerhans. Histochemistry 38, 27-33
4. Westermark P, Wernstedt C, Wilander E and Sletten K (1986). A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140, 827-831
5. Westermark P, Li Z-C, Westermark GT, Leckström A and Steiner DF (1996). Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett 379, 203-206
6. Hellman U, Wernstedt C, Westermark P, O'Brien TD, Rathbun WB and Johnson KH (1990). Amino acid sequence from degu islet amyloid-derived insulin shows unique sequence characteristics. Biochem Biophys Res Commun 169, 571-577
7. Maloy AL, Longnecker DS and Greenberg ER (1981). The relation of islet amyloid to the clinical type of diabetes. Hum Path 12, 917-922
8. Westermark P (1995). Islet amyloid polypeptide and amyloid in the islets of Langerhans. In Leslie RDG and Robbins D (ed.) Diabetes: Clinical Science in Practice, pp. 189-199. (Cambridge: Cambridge Press University)
9. Lorenzo A, Razzaboni B, Weir GC and Yankner BA (1994). Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368, 756-760
10. Janson J, Ashley RH, Harrison D, McIntyre S and Butler PC (1999). The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491-498
11. Westermark P and Grimelius L (1973). The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A 81, 291-300
12. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR and Turner RC (1988). Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diab Res 9, 151-159
13. de Koning EPJ, Morris ER, Hofhuis FM A, Posthuma G, Höppener JWM, Morris JF, Capel PJA, Clark A and Verbeek JS (1994). Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 91, 8467-8471
14. Westermark G, Benig Arora M, Fox N, Carroll R, Chan SJ, Westermark P and Steiner DF (1995). Amyloid formation in response to β cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med 1, 542-553
15. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG and Kahn SE (1996). Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93, 3492-3496
16. Westermark P, Eizirik DL, Pipeleers DG, Hellerström C and Andersson A (1995). Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38, 543-549
17. Hinton DR, Polk RK, Linse KD, Weiss MH, Kovacs K and Garner JA (1997). Characterization of spherical amyloid protein from a prolactin-producing pituitary adenoma. Acta Neuropath 93, 43-49
18. Westermark P, Eriksson L, Engström U, Eneström S and Sletten K (1997). Prolactin-derived amyloid in the aging pituitary gland. Am J Path 150, 67-73
19. Röcken C and Saeger W (1994). Amyloid deposits of the pituitary in old age: correlation with histopathological alterations. Endocrine Path 5, 183-190
20. Westermark P, Johansson B and Natvig JB (1979) Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol 10, 303-308
21. Johansson B and Westermark P (1991). Isolated atrial amyloidosis. Increased frequency in patients with congestive cardiac failure. In Natvig JB, Førre Ø, Husby G, Husebekk A, Skogen B, Sletten K and Westermark P (ed.) Amyloid and Amyloidosis 1990, pp. 474-476. (Dordrecht: Kluwer)
22. Looi L-M (1993). Isolated atrial amyloidosis. A clinicopathologic study indicating increased prevalence in chronic heart disease. Hum Path 24, 602-607
23. Westermark P, Engström U, Westermark GT, Johnson KH, Permerth J and Betsholtz C (1989). Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. Diab Res Clin Pract 7, 219-226